Health Condition 1: C23- Malignant neoplasm of gallbladder
Conditions
Interventions
Intervention1: Homoeopathic medicine add on with Institutional management protocol of
CAGB
: Homoeopathic medicines as detailed in the standard Homoeopathic Materia Medica and in the Homoeopathic Phar
Sponsors
Director General, CCRH
Eligibility
Inclusion criteria
Inclusion criteria: 1. FNAC or biopsy-diagnosed cases of unresectable Stage III/IV Gall bladder cancer 2. Age 18 years and above. 3. Gender: Both Male and Female. 4. Willing to give informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients who are immune-compromised due to disease conditions like HIV-AIDS, bone marrow aplasia or any other condition which is not accounted due to pathogenesis of the disease or chemotherapeutic treatment or radiological treatment. 2. Unwilling to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival timeTimepoint: Every month from the baseline to 12 months or till the patient survive, which one is earlier | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Tumor Response, Quality of life 2.ECOG PS Status 3.Adverse Events and Serious 4.Adverse Events Timepoint: 1.Base line , 04 month,8 month, 12 months.(as and when if required), 2.Every month from the baseline to 12 months or till the patient survive, which one is earlier 3.Every month from the baseline to 12 months or till the patient survive, which one is earlier 4. Every Follow up | — |
Countries
India
Contacts
Public ContactDr Ratan Chandra Shil
RRI(H),Agartala
Outcome results
None listed